News
RMD
198.03
+0.87%
1.70
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK)
TipRanks · 1d ago
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
ResMed is one of the largest respiratory care device companies globally. The average price target for ResMed is $203.22. ResMed has a 12-month price target of $227.00. 9 analysts have shared their insights on ResMed in the last three months. The company is a leader in the sleep apnea market.
Benzinga · 1d ago
ResMed Price Target Maintained With a $215.00/Share by Mizuho
Dow Jones · 1d ago
ResMed Is Maintained at Buy by Mizuho
Dow Jones · 1d ago
Peering Into ResMed's Recent Short Interest
ResMed's short percent of float has risen 4.07% since its last report. The company has 6.58 million shares sold short, which is 5.11% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 2d ago
ResMed Still Showing Value Amid Weight-Loss Drug Trials -- Market Talk
Analysts expect limited implications for continuous positive airway pressure treatments if Eli Lilly announces positive results from weight-loss drug trial. Wilsons stays overweight on the stock and lifts target price 5.2% to A$32.90. ResMed shares are down 1.15%.
Dow Jones · 3d ago
*ResMed Price Target Raised 5% to A$32.90/Share by Wilsons
Dow Jones · 3d ago
Weekly Report: what happened at RMD last week (0318-0322)?
Weekly Report · 3d ago
With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
ResMed (NYSE:RMD) is a company that is growing profits. The company has grown its earnings per share by 7.9% per year over the last three years. ResMed has a high level of insider ownership in the company, worth US$247m. Insiders have a stake in ResMed worth 0.9%. The company is growing its revenue and profits while growing its market value.
Simply Wall St · 6d ago
Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Mineralys Therapeutics, Inc. (MLYS) and Addus Homecare (ADUS)
TipRanks · 6d ago
Analysts Are Bullish on These Healthcare Stocks: Addus Homecare (ADUS), Resmed (RMD)
TipRanks · 6d ago
Weekly Report: what happened at RMD last week (0311-0315)?
Weekly Report · 03/18 09:18
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
ResMed announces results of its 2024 Global Sleep Survey in conjunction with World Sleep Day. The survey sheds light on the critical sleep challenges faced by people around the world. ResMed is the global leader in digital health and cloud-connected medical devices for sleep apnea and other chronic diseases.
Barchart · 03/15 02:05
UBS sees Lilly GLP-1/sleep apnea study falling short of Street estimates
Healthcare UBS sees Lilly GLP-1/sleep apnea study falling short of Street estimates. Eli Lilly’s drug tirzepatide in the treatment of sleep apnea will come in below Street expectations. UBS said it sees the study demonstrating weight loss of 12-14% and AHI reduction of 30-37% from baseline.
Seeking Alpha · 03/14 15:44
Weekly Report: what happened at RMD last week (0304-0308)?
Weekly Report · 03/11 09:18
Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
ResMed's (NYSE:RMD) Return on Capital Employed (ROCE) is 20%. The company has earned an ROCE of 20% over the last five years. ResMed is better than the Medical Equipment industry average of 9.6%. ResMed has been reinvesting at a high rate of return. The company's ROCe is a good indicator of its ability to reinvest in itself.
Simply Wall St · 03/10 13:36
Dividend Champion, Contender, And Challenger Highlights: Week Of March 10
Home Dividends Analysis Dividend Quick Picks: Week of March 10, 2014. A weekly summary of dividend activity for D dividend Champions, Contenders, and Challengers. Companies on the D dividend champion list have consistently increased their annual dividend payouts. General Dynamics Corporation and Horace Mann Educators are among the companies to have increased their dividends.
Seeking Alpha · 03/10 12:39
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
NASDAQ · 03/08 14:50
ResMed (RMD) Debuts the Smallest Full-Face CPAP Mask AirFit F40
NASDAQ · 03/07 12:33
Noteworthy Wednesday Option Activity: DOCU, UNH, RMD
NASDAQ · 03/06 20:33
More
Webull provides a variety of real-time RMD stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.